Evaxion A EVAX
NASDAQ EVAX
$2.75 -0.25 (-8.33%)
At close: Nov 9, 2026 · 4:00 PM EST

Evaxion A (EVAX) EBIT Margin (2023 - 2025)

Updated

Evaxion A's EBIT Margin was -122.66% in FY2025, up 317.89 percentage points from -440.55% in FY2024.

Analysis

Evaxion A (EVAX) EBIT Margin (2023 - 2025) Analysis & Trends

  • Per Business Quant data, EBIT Margin in earlier years was -440.55% in FY2024 (+29966.30 pp) and -30406.85% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 52.42%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 24.35%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 36.01%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 30.89%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 29.12%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 35.79%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 41.71%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 32.98%
10 Evaxion A 17.56 Mn -48.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 40.34%
Jun 30, 2025 -11,729.73%
Dec 31, 2024 -3,298.36%
Sep 30, 2024 -57.37%
Jun 30, 2024 -2,974.68%
Mar 31, 2024 -8,619.61%
Dec 31, 2023 -588.93%
API Access

Evaxion A EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=EVAX&period=max&api_key=YOUR_API_KEY